EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Understanding Alpha‐Gal Syndrome: A Systematic Review and Meta‐Analysis of Clinical Manifestations and Outcomes

Sameer Rao iD, Sawai Singh Rathore, Ritik Mahaveer Goyal, Amy Narakornpichit iD, Rohan Karkra iD, Ahmed Al-Khazraji, Madhusudan Grover

Neurogastroenterology & Motility · 2026-01 · 38 (1)

DOI: 10.1111/nmo.70245 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 19.01.2026. Verfasst von Sameer Rao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Food Hypersensitivity, Tick Bites. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Alpha‐gal syndrome (AGS) is an IgE‐mediated hypersensitivity to galactose‐α‐1,3‐galactose, triggered by tick bites. It typically presents with delayed onset allergic or gastrointestinal symptoms after red meat consumption. This study aims to evaluate the prevalence of clinical symptoms and outcomes in AGS patients.

Methods

A systematic search of PubMed, Embase, and Cochrane Central was conducted to identify studies with at least five AGS patients that utilized alpha‐gal IgE for diagnosis and reported symptomatology. A random‐effects model calculated pooled prevalence and 95% confidence intervals (CIs) for clinical characteristics of AGS.

Results

Of the 739 studies screened, 15 met the inclusion criteria, comprising 1162 AGS patients (57% female). Urticaria was identified as the most prevalent symptom (63.8%, CI: 34.5–88.3, I 2 = 98.8%). At least one gastrointestinal symptom was reported in 69.2% of patients (CI: 49.3–85.9, I 2 = 97.5%), including abdominal pain (58.3%, CI: 36.0–78.9, I 2 = 96.0%), diarrhea (41.7%, CI: 22.3–62.5, I 2 = 93.4%), nausea (39.1%, CI: 29.2–49.6, I 2 = 79.1%), and vomiting (31.1%, CI: 21.9–41.2, I 2 = 70.4%). Tick bite history was recalled by 78.7% (CI: 46.4–98.1; I 2 = 99.1%), and 91.8% (CI: 84.6–96.8; I 2 = 70.3%) had symptom onset ≥ 1 h post red meat intake. Symptomatic improvement was observed in 86.5% (CI: 73.9–95.4, I 2 = 80.9%) of patients, with complete resolution in 42.7% (CI: 26.4–59.8, I 2 = 73.8%).

Conclusion

AGS typically presents with delayed onset allergic and GI symptoms after red meat intake, often with tick bite history. Majority of patients report symptomatic improvement on follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityTick BitesHumansRed MeatImmunoglobulin E

Stichwörter der Autor:innen

alpha‐gal syndromegalactose‐α‐1,3‐galactosetick bite

Substanzen

Immunoglobulin E

Autor:innen und Institutionen

  • Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dr Sampurnanand Medical College, Jodhpur, Rajasthan, India.
  • Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

ORCID-Profile: Sameer Rao, Amy Narakornpichit, Rohan Karkra

Zitieren

APA

Rao, S., Rathore, S. S., Goyal, R. M., Narakornpichit, A., Karkra, R., Al-Khazraji, A., & Grover, M. (2026). Understanding Alpha‐Gal Syndrome: A Systematic Review and Meta‐Analysis of Clinical Manifestations and Outcomes. Neurogastroenterology & Motility, 38(1). https://doi.org/10.1111/nmo.70245

Vancouver

Rao S, Rathore SS, Goyal RM, Narakornpichit A, Karkra R, Al-Khazraji A, et al. Understanding Alpha‐Gal Syndrome: A Systematic Review and Meta‐Analysis of Clinical Manifestations and Outcomes. Neurogastroenterology & Motility. 2026;38(1). doi:10.1111/nmo.70245

BibTeX
@article{Rao2026,
  author = {Rao, Sameer and Rathore, Sawai Singh and Goyal, Ritik Mahaveer and Narakornpichit, Amy and Karkra, Rohan and Al-Khazraji, Ahmed and Grover, Madhusudan},
  title = {Understanding Alpha‐Gal Syndrome: A Systematic Review and Meta‐Analysis of Clinical Manifestations and Outcomes},
  journal = {Neurogastroenterology & Motility},
  year = {2026},
  volume = {38},
  number = {1},
  doi = {10.1111/nmo.70245}
}
Kostenlos starten →